Kiora Total Assets vs Asset Turnover Analysis

KPRX Stock  USD 0.62  0.01  1.64%   
Kiora Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Kiora Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kiora Pharmaceuticals is a good investment. Please check the relationship between Kiora Pharmaceuticals Total Assets and its Asset Turnover accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Total Assets vs Asset Turnover

Total Assets vs Asset Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kiora Pharmaceuticals Total Assets account and Asset Turnover. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Kiora Pharmaceuticals' Total Assets and Asset Turnover is -0.31. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of Kiora Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Kiora Pharmaceuticals' Total Assets and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Kiora Pharmaceuticals are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Total Assets i.e., Kiora Pharmaceuticals' Total Assets and Asset Turnover go up and down completely randomly.

Correlation Coefficient

-0.31
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Assets

Total assets refers to the total amount of Kiora Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kiora Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.
Most indicators from Kiora Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kiora Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.At this time, Kiora Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 8.7 M in 2024, whereas Tax Provision is likely to drop (136.5 K) in 2024.

Kiora Pharmaceuticals fundamental ratios Correlations

-0.490.870.230.930.73-0.68-0.820.310.670.88-0.50.670.430.26-0.880.820.95-0.870.76-0.520.490.47-0.730.610.65
-0.49-0.540.04-0.55-0.260.690.33-0.03-0.52-0.30.76-0.52-0.23-0.160.51-0.42-0.440.55-0.541.0-0.3-0.290.3-0.13-0.21
0.87-0.540.450.820.57-0.62-0.70.620.60.75-0.510.60.420.24-0.840.730.82-0.770.68-0.550.30.62-0.510.540.5
0.230.040.450.18-0.04-0.32-0.010.560.390.080.220.39-0.15-0.13-0.360.420.1-0.140.350.050.340.880.26-0.18-0.24
0.93-0.550.820.180.56-0.69-0.790.30.690.77-0.60.690.470.33-0.970.80.92-0.990.76-0.570.510.42-0.690.430.56
0.73-0.260.57-0.040.56-0.5-0.670.110.530.6-0.330.530.460.25-0.450.480.7-0.480.61-0.270.170.15-0.710.660.7
-0.680.69-0.62-0.32-0.69-0.50.31-0.15-0.96-0.270.51-0.96-0.140.090.71-0.57-0.530.69-0.950.67-0.61-0.450.31-0.03-0.08
-0.820.33-0.7-0.01-0.79-0.670.31-0.11-0.35-0.820.45-0.35-0.77-0.720.68-0.61-0.890.7-0.480.36-0.26-0.340.91-0.7-0.91
0.31-0.030.620.560.30.11-0.15-0.110.150.310.090.150.01-0.15-0.410.320.25-0.290.18-0.03-0.050.370.110.21-0.01
0.67-0.520.60.390.690.53-0.96-0.350.150.24-0.411.00.21-0.02-0.710.560.51-0.670.98-0.50.650.49-0.350.030.12
0.88-0.30.750.080.770.6-0.27-0.820.310.24-0.380.240.360.3-0.70.760.9-0.70.35-0.350.260.32-0.70.750.74
-0.50.76-0.510.22-0.6-0.330.510.450.09-0.41-0.38-0.41-0.36-0.270.53-0.38-0.520.62-0.460.77-0.26-0.090.45-0.27-0.38
0.67-0.520.60.390.690.53-0.96-0.350.151.00.24-0.410.21-0.02-0.710.560.51-0.670.98-0.50.650.49-0.350.030.12
0.43-0.230.42-0.150.470.46-0.14-0.770.010.210.36-0.360.210.89-0.340.030.54-0.410.35-0.23-0.030.09-0.670.610.8
0.26-0.160.24-0.130.330.250.09-0.72-0.15-0.020.3-0.27-0.020.89-0.210.040.42-0.260.1-0.170.020.14-0.610.430.74
-0.880.51-0.84-0.36-0.97-0.450.710.68-0.41-0.71-0.70.53-0.71-0.34-0.21-0.83-0.860.97-0.770.53-0.55-0.540.55-0.28-0.39
0.82-0.420.730.420.80.48-0.57-0.610.320.560.76-0.380.560.030.04-0.830.76-0.760.57-0.450.520.64-0.490.250.35
0.95-0.440.820.10.920.7-0.53-0.890.250.510.9-0.520.510.540.42-0.860.76-0.880.63-0.470.390.37-0.820.620.73
-0.870.55-0.77-0.14-0.99-0.480.690.7-0.29-0.67-0.70.62-0.67-0.41-0.260.97-0.76-0.88-0.740.57-0.5-0.350.63-0.34-0.47
0.76-0.540.680.350.760.61-0.95-0.480.180.980.35-0.460.980.350.1-0.770.570.63-0.74-0.530.610.48-0.460.160.26
-0.521.0-0.550.05-0.57-0.270.670.36-0.03-0.5-0.350.77-0.5-0.23-0.170.53-0.45-0.470.57-0.53-0.29-0.290.31-0.18-0.25
0.49-0.30.30.340.510.17-0.61-0.26-0.050.650.26-0.260.65-0.030.02-0.550.520.39-0.50.61-0.290.37-0.3-0.2-0.02
0.47-0.290.620.880.420.15-0.45-0.340.370.490.32-0.090.490.090.14-0.540.640.37-0.350.48-0.290.37-0.050.020.08
-0.730.3-0.510.26-0.69-0.710.310.910.11-0.35-0.70.45-0.35-0.67-0.610.55-0.49-0.820.63-0.460.31-0.3-0.05-0.59-0.83
0.61-0.130.54-0.180.430.66-0.03-0.70.210.030.75-0.270.030.610.43-0.280.250.62-0.340.16-0.18-0.20.02-0.590.88
0.65-0.210.5-0.240.560.7-0.08-0.91-0.010.120.74-0.380.120.80.74-0.390.350.73-0.470.26-0.25-0.020.08-0.830.88
Click cells to compare fundamentals

Kiora Pharmaceuticals Account Relationship Matchups

Kiora Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.1M15.2M18.1M18.7M13.7M11.7M
Short Long Term Debt Total83.9K362.1K209.4K105.8K106.9K101.5K
Other Current Liab1.1M1.3M1.3M2.2M1.4M1.3M
Total Current Liabilities1.4M1.8M1.6M3.3M1.6M3.2M
Total Stockholder Equity6.6M7.0M9.2M11.4M6.1M6.4M
Property Plant And Equipment Net16.8K30.6K283.4K172.2K115.0K76.8K
Net Debt(3.7M)(823.6K)(7.6M)(5.9M)(2.3M)(2.5M)
Retained Earnings(100.2M)(108.3M)(124.7M)(134.5M)(147.0M)(154.3M)
Accounts Payable210.3K434.8K160.6K1.0M206.3K195.9K
Cash3.8M1.2M7.9M6.0M2.5M4.7M
Non Current Assets Total5.8M13.3M9.1M11.0M9.0M6.1M
Non Currrent Assets Other114.4K102.1K88.0K82.3K40.8K38.7K
Cash And Short Term Investments3.8M1.2M7.9M6.0M2.5M4.7M
Net Receivables4.9K91.0K529.6K1.4M2.0M2.2M
Common Stock Shares Outstanding79.5K114.8K241.1K732.3K4.8M5.1M
Liabilities And Stockholders Equity10.1M15.2M18.1M18.7M13.7M11.7M
Non Current Liabilities Total2.1M6.4M7.2M4.0M6.0M10.2M
Other Current Assets542.7K533.5K606.5K343.1K233.4K368.7K
Other Stockholder Equity106.7M115.3M133.9M146.0M153.2M93.1M
Total Liab3.5M8.2M8.8M7.3M7.6M12.5M
Total Current Assets4.3M1.8M9.0M7.7M4.7M5.6M
Accumulated Other Comprehensive Income139.5K(802.0)(86.4K)(182.7K)(182.8K)(173.7K)
Short Term Debt83.9K48.3K118.8K105.8K47.1K44.7K
Common Stock40.8K55.6K126.6K18.0K77.1K101.9K
Intangible Assets4.1M9.7M8.7M10.7M8.8M7.9M
Other Liab1.5M2.1M6.1M7.1M8.2M8.6M
Net Tangible Assets7.2M4.9M3.3M9.1M10.4M10.9M
Capital Lease Obligations83.9K83.9K209.4K105.8K121.6K92.4K
Net Invested Capital6.6M7.3M9.2M11.4M13.1M7.6M
Non Current Liabilities Other1.7M5.3M6.5M3.3M3.8M3.5M
Net Working Capital2.9M37.8K7.4M4.4M5.1M5.3M
Property Plant Equipment43.5K16.8K30.6K283.4K325.9K342.2K
Capital Stock40.8K55.6K126.6K18.0K16.2K15.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Kiora Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiora Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiora Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiora Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Kiora Stock analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.78
Revenue Per Share
0.002
Return On Assets
(0.38)
Return On Equity
(1.37)
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.